Recent Finacing
Recent Raise
Opsonix develops an extracorporeal dialyzer therapy using FcMBL-engineered pathogen-capture proteins affixed to membrane cartridges to remove bacteria, fungi, parasites, viruses, and circulating toxins, complementary to antibiotics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor